Hematology NewsSafely skip PET2 after brentuximab in Hodgkin lymphoma?September 13, 2023B Cell LymphomaDLBCLAggressive Lymphomas
Hematology News‘Promising’ new txs for most common adult leukemiaSeptember 8, 2023CLLCellular TherapyMixed TopicsB Cell Lymphoma
Hematology NewsLymphoma specialist to lead MD Anderson’s cancer medicine divisionAugust 22, 2023B Cell LymphomaMixed TopicsMantle Cell LymphomaDiversity in Medicine
Hematology NewsAntibody shows promise in preventing GVHDAugust 8, 2023TransplantMixed TopicsMultiple MyelomaNon-Hodgkin LymphomaHodgkin LymphomaB Cell LymphomaCLL
Hematology NewsESMO helps hematologists assess new cancer drugsJune 28, 2023Mixed TopicsCellular TherapyCMLCLLAggressive LymphomasALLAML
NORD: Making Progress Through CollaborationJune 26, 2023Rare DiseasesALLAMLB Cell LymphomaHead & Neck/Thyroid CancersOvarian CancerLung Cancer
Oncology PracticeMultiprong strategy makes clinical trials less WhiteJune 23, 2023Diversity in MedicinePatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Oncology PracticeHuge underuse of germline testing for cancer patientsJune 22, 2023Patient & Survivor CarePreventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Oncology PracticeDEI training gives oncology fellows more confidenceJune 22, 2023Diversity in MedicinePractice ManagementRenal Cell CarcinomaSarcoma & GISTCNS/Brain CancerDLBCLFollicular Lymphoma
Oncology PracticeDrugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Patient & Survivor CarePractice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Hematology NewsCAR-T hikes overall survival in relapsed/refractory LBCLJune 9, 2023B Cell LymphomaCellular Therapy
Oncology PracticeWidespread carboplatin, cisplatin shortages: NCCN surveyJune 9, 2023Patient & Survivor CarePractice ManagementLung CancerBreast CancerGenitourinary CancerNonmelanoma Skin CancerMetastatic Breast Cancer
